Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHEK1 | O14757 | 1/20 | 0.39 |
| ▸ | HSD17B1 | P14061 | 2/20 | 0.37 |
| ▸ | ACACB | O00763 | 8/20 | 0.35 |
| ▸ | ACACA | Q13085 | 8/20 | 0.35 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | PGR | P06401 | 1/20 | 0.33 |
| ▸ | ERN1 | O75460 | 1/20 | 0.33 |
| ▸ | RARA | P10276 | 1/20 | 0.33 |
| ▸ | RARB | P10826 | 1/20 | 0.33 |
| ▸ | RARG | P13631 | 1/20 | 0.33 |
| ▸ | KMO | O15229 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | RAD51 | Q06609 | 1/20 | 0.32 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11940681 | 0.88 | PGR (0.44) | HSD17B1ACACBACACAPGRRARA | |
| SCHEMBL11940686 | 0.85 | ACACB (0.44) | HSD17B1ACACBACACAPGR | |
| SCHEMBL11940676 | 0.85 | ACACB (0.41) | HSD17B1ACACBACACAPGRRARA | |
| SCHEMBL11940743 | 0.84 | CHEK1 (0.39) | CHEK1HSD17B1ACACBACACADYRK1A | |
| SCHEMBL12119162 | 0.84 | HSD17B1 (0.40) | CHEK1HSD17B1DYRK1AALDH1A1MAPT | |
| SCHEMBL11940696 | 0.83 | AHR (0.34) | HSD17B1PGRRARARARBRARG | |
| SCHEMBL11940684 | 0.82 | COMT (0.37) | ACACBACACAALDH1A1MAPTPGR | |
| SCHEMBL11940725 | 0.82 | HSD17B1 (0.46) | CHEK1HSD17B1DYRK1AALDH1A1MAPT | |
| SCHEMBL11940692 | 0.81 | ACACB (0.33) | HSD17B1ACACBACACAPGR | |
| SCHEMBL11940694 | 0.81 | P2RX7 (0.36) | HSD17B1ACACBACACAPGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8741806-B2 | Herbicides | SYNGENTA LIMITED (GB) | 2014-06-03 | — | — | US | disclosed |
| US-8741806-B2 | Herbicides | SYNGENTA LIMITED (GB) | 2014-06-03 | — | — | US | disclosed |
| US-20120190545-A1 | NOVEL HERBICIDES | SYNGENTA CROP PROTECTION LLC (US) | 2012-07-26 | — | — | US | disclosed |
| US-20120190545-A1 | NOVEL HERBICIDES | SYNGENTA CROP PROTECTION LLC (US) | 2012-07-26 | — | — | US | disclosed |
| WO-2011006543-A1 | NOVEL HERBICIDES | SYNGENTA LIMITED (GB) | 2011-01-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120190545-A1 | NOVEL HERBICIDES | DDT, CYP1B1, CYP1A1 | CHEK1 3266/4885HSD17B1 320/4885ACACB 1002/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.